PMID- 38348340
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240214
IS  - 1687-8760 (Print)
IS  - 1687-8779 (Electronic)
IS  - 1687-8760 (Linking)
VI  - 2024
DP  - 2024
TI  - Prioritizing Asthma Treatment Drugs through Multicriteria Decision Making.
PG  - 6516976
LID - 10.1155/2024/6516976 [doi]
LID - 6516976
AB  - Asthma is a medical condition characterized by inflammation, narrowing, and 
      swelling of a person's airways, leading to increased mucus production and 
      difficulties in breathing. Topological indices are instrumental in assessing the 
      physical and chemical attributes of these asthma drugs. As resistance to current 
      treatments continues to emerge and undesirable side effects are linked to certain 
      medications, the search for novel and enhanced drugs becomes a top priority. In 
      this study, the examination of 19 distinct asthma medications was focused. In 
      this study, quantitative structure-activity relationship (QSAR) and quantitative 
      structure-property relationship (QSPR) modeling, in combination with 
      multicriteria decision-making (MCDM) technique VIKOR (VIekriterijumsko 
      KOmpromisno Rangiranje) were employed on asthma drugs, to achieve the most 
      favorable rankings for each asthma drug, taking into account their distinct 
      properties. The topological indices employed for QSPR modeling were Randic index, 
      reciprocal Randic index, Zagreb indices, hyper-Zagreb index, harmonic index, 
      geometric arithmetic index, and forgotten index.
CI  - Copyright (c) 2024 Sobia Sultana.
FAU - Sultana, Sobia
AU  - Sultana S
AUID- ORCID: 0009-0004-8599-5509
AD  - Department of Mathematics and Statistics, Faculty of Science, Imam Mohammad Ibn 
      Saud Islamic University (IMSIU), P.O. Box 90950, Riyadh 11623, Saudi Arabia.
LA  - eng
PT  - Journal Article
DEP - 20240205
PL  - Egypt
TA  - Int J Anal Chem
JT  - International journal of analytical chemistry
JID - 101519424
PMC - PMC10861281
COIS- The author declares that there are no conflicts of interest.
EDAT- 2024/02/13 06:45
MHDA- 2024/02/13 06:46
PMCR- 2024/02/05
CRDT- 2024/02/13 03:51
PHST- 2023/11/07 00:00 [received]
PHST- 2024/01/14 00:00 [revised]
PHST- 2024/01/20 00:00 [accepted]
PHST- 2024/02/13 06:46 [medline]
PHST- 2024/02/13 06:45 [pubmed]
PHST- 2024/02/13 03:51 [entrez]
PHST- 2024/02/05 00:00 [pmc-release]
AID - 10.1155/2024/6516976 [doi]
PST - epublish
SO  - Int J Anal Chem. 2024 Feb 5;2024:6516976. doi: 10.1155/2024/6516976. eCollection 
      2024.